Vimarsana
Biggest News Aggregation in the World

Wenn Sun News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wenn Sun. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wenn Sun Today - Breaking & Trending Today

AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for selpercatinib RET fusion positive NSCLC - Vimarsana News

AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for selpercatinib RET fusion positive NSCLC

TOKYO and XIAMEN, China, March 27, 2023 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., and Precision Medicine Asia Co., Ltd. today announced that the Japanese Ministry of Health, Labour... | March 27, 2023

AmoyDx® Pan Lung Cancer PCR Panel Receives MHLW Approval as - Vimarsana News

AmoyDx® Pan Lung Cancer PCR Panel Receives MHLW Approval as

AmoyDx® Pan Lung Cancer PCR Panel Receives MHLW Approval as Companion Diagnostic for 9 Targeted Therapies for Use in Patients with Advanced Non-Small Cell Lung Cancer PREMIA Holdings (HK) Ltd. Hong Kong, HONG KONG TOKYO and XIAMEN, China, June 30, 2021 (GLOBE NEWSWIRE) -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co., Ltd. (“PREMIA”) today announced that the AmoyDx ® Pan Lung Cancer PCR Panel (the “AmoyDx PLC Panel”), an in vitro diagnostic reagent developed as a companion diagnostic for multiple anti...

Kinnate Biopharma Inc. Closes $35 Million Series A - Vimarsana News

Kinnate Biopharma Inc. Closes $35 Million Series A

Kinnate Biopharma Inc. Closes $35 Million Series A Financing to Establish a Chinese Joint Venture May 13, 2021 16:02 ET | Source: Kinnate Biopharma Kinnate Biopharma Financing led by OrbiMed Asia Partners, with participation from OrbiMed Private Investments and Foresite Capital The joint venture will have exclusive license to develop and commercialize Kinnate’s currently most advanced kinase inhibitor candidates in Greater China Veteran biopharmaceutical industry executive Wenn Sun, Ph.D. has been named as Executive Chair SAN FRANCISCO and SAN DIEGO, May 13, 2021 ...